A novel approach to CRISPR
Dual gRNAs excise large sections of viral DNA, eliminating viral escape and reproduction. The result is curative.
No Probability of Escape
Excision's platform enables in silico design of probes to analyze on- and off-target effects and integrates computational methods to design the most effective guide RNAs.
We are transforming drug discovery and target validation from traditional to digital.
Pre-Clinical In Vitro Studies
Pre-Clinical In Vivo Studies
EBT-101 HIV AAV9 Cas9 dual gRNA Therapeutic
EBT-103 PML/JCV AAV9 Cas9 triplet gRNA T-antigen Therapeutic
EBT-104 HSV AAV or non-viral Cas9 quad gRNA Therapeutic
EBT-107 HBV AAV or non-viral CasX dual gRNA Therapeutic
EBT-201 COVID-19 Treatment & Prevention: CasY, Cas9, Cas13a